Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Pfeffer

Showing results (221-230 of 520) with videos related to

Pageof 52
Sort By:
The American Journal of Cardiology|September 22, 2010
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunctionAmil M Shah, Marc A Pfeffer, L Howard Hartley, et al.
Journal of the American College of Cardiology|November 20, 2010
Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarctionChung-Lieh Hung, Anil Verma, Hajime Uno, et al.
American Heart Journal|August 1, 2006
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery diseaseDavid Aguilar, Marian R Fisher, Christopher M O'Connor, et al.
American Heart Journal|August 10, 2005
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic studyScott D Solomon, Hicham Skali, Mikhail Bourgoun, et al.
Cardiovascular Drugs and Therapy|September 27, 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical OutcomesSøren L Kristensen, Pardeep S Jhund, Matthew M Y Lee, et al.
Diabetologia|November 4, 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trialJelena P Seferovic, Marc A Pfeffer, Brian Claggett, et al.
European Journal of Heart Failure|November 18, 2017
Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trialSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
Circulation|August 29, 2007
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failureScott D Solomon, Joanna Dobson, Stuart Pocock, et al.
Circulation. Heart Failure|October 19, 2014
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fractionAkshay S Desai, Brian Claggett, Marc A Pfeffer, et al.
Journal of the American College of Cardiology|February 16, 2018
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial FibrillationJoão Pedro Ferreira, Nicolas Girerd, John Gregson, et al.
Pageof 52

Showing results (221-230 of 520) with videos related to

Sort By:
Pageof 52
The American Journal of Cardiology|September 22, 2010
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunctionAmil M Shah, Marc A Pfeffer, L Howard Hartley, et al.
Journal of the American College of Cardiology|November 20, 2010
Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarctionChung-Lieh Hung, Anil Verma, Hajime Uno, et al.
American Heart Journal|August 1, 2006
Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery diseaseDavid Aguilar, Marian R Fisher, Christopher M O'Connor, et al.
American Heart Journal|August 10, 2005
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic studyScott D Solomon, Hicham Skali, Mikhail Bourgoun, et al.
Cardiovascular Drugs and Therapy|September 27, 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical OutcomesSøren L Kristensen, Pardeep S Jhund, Matthew M Y Lee, et al.
Diabetologia|November 4, 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trialJelena P Seferovic, Marc A Pfeffer, Brian Claggett, et al.
European Journal of Heart Failure|November 18, 2017
Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trialSenthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
Circulation|August 29, 2007
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failureScott D Solomon, Joanna Dobson, Stuart Pocock, et al.
Circulation. Heart Failure|October 19, 2014
Influence of hospitalization for cardiovascular versus noncardiovascular reasons on subsequent mortality in patients with chronic heart failure across the spectrum of ejection fractionAkshay S Desai, Brian Claggett, Marc A Pfeffer, et al.
Journal of the American College of Cardiology|February 16, 2018
Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial FibrillationJoão Pedro Ferreira, Nicolas Girerd, John Gregson, et al.
Pageof 52